Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Martin, Laclav"'
Autor:
Pavel Škrha, Jan Škrha, Miroslav Zavoral, Přemysl Frič, Petr Busek, Martin Laclav, Aleksi Sedo
Publikováno v:
European Journal of Gastroenterology & Hepatology. 29:885-891
Sporadic pancreatic cancer amounts to ∼90% of all pancreatic cancers. It is a gloomy depressive disease and the most recalcitrant malignancy, with a very low 5-year survival (3-6%). At present, diagnostic methods are commonly applied, as used half
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0c585c2ecae1b0bcdd88096018112f
https://doi.org/10.1097/meg.0000000000000904
https://doi.org/10.1097/meg.0000000000000904
Autor:
Petr Hrabal, Petr Busek, Klára Kmochová, Jan Škrha, Jana Uhrova, Přemysl Frič, Martin Laclav, Bohus Bunganic
Publikováno v:
Pancreatology. 17:89-94
The changes in gastrointestinal hormones associated with pancreatic ductal adenocarcinoma (PDAC) in patients with impaired glucoregulation have yet to be evaluated. The aim of this study was to determine plasma concentrations of selected gastrointest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf351b03c74d02e0e5b3cfa54e4a882
https://doi.org/10.1016/j.pan.2016.12.004
https://doi.org/10.1016/j.pan.2016.12.004
Autor:
Bohus Bunganic, Přemysl Frič, Stepan Suchanek, Miroslav Zavoral, Martin Laclav, T Dvořáková, Eva Traboulsi, O Bradáč
Publikováno v:
Scandinavian journal of gastroenterology. 53(10-11)
The main objective is to compare the accuracy of EUS and CEH EUS for the diagnosis of pancreatic cancer (PC). The secondary objective is to evaluate the accuracy of EUS FNA and to determine to what extent EUS and CEH EUS findings are affected by endo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ed1843eddf9d8244fa59abb5059961
https://pubmed.ncbi.nlm.nih.gov/30394143
https://pubmed.ncbi.nlm.nih.gov/30394143
Autor:
Ondřej Májek, Bohus Bunganic, Štěpán Suchánek, Eva Traboulsi, Martin Laclav, Tereza Dvořáková, Klára Krnochová, Miroslav Zavoral
Publikováno v:
Gastroenterologie a hepatologie. 68:430-435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f426949749ee23d03606eac9a718f598
https://doi.org/10.14735/amgh2014430
https://doi.org/10.14735/amgh2014430
Autor:
Martin Laclav, Přemysl Frič, Aleksi Sedo, Jan Škrha, Petr Busek, Bohus Bunganic, Miroslav Zavoral
Publikováno v:
European journal of gastroenterologyhepatology. 29(3)
Pancreatic cancer (PC) behaves very differently in comparison with other malignancies. Its incidence has been increasing continuously; mortality has not decreased, the diagnosis is frequently late, radical surgery is performed only in 15-20% of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a6a208354b71d7ccd1cc2bbfff9dac
https://pubmed.ncbi.nlm.nih.gov/28009716
https://pubmed.ncbi.nlm.nih.gov/28009716
Autor:
Svatopluk Solař, Aleksi Sedo, Pavel Škrha, Miroslav Zavoral, Petr Busek, Tomáš Zima, Petr Hrabal, Přemysl Frič, Bohus Bunganic, Jan Škrha, Martin Laclav, Pavel Záruba, Klára Kmochová, František Bělina
Publikováno v:
European journal of gastroenterologyhepatology. 28(12)
High-resolution imaging methods (HRIMs) and biomarkers present the second step of pancreatic cancer (PC) diagnostics in at-risk individuals. These include patients with positive risk factors, early symptoms, nonresponders to the initial antidiabetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fee11b032bff474823bf9499e51980
https://pubmed.ncbi.nlm.nih.gov/27769077
https://pubmed.ncbi.nlm.nih.gov/27769077
Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs
Autor:
Martin Laclav, Bohus Bunganic, Jan Škrha, Přemysl Frič, Miroslav Zavoral, Svatopluk Solař, Klára Kmochová, Aleksi Sedo, Petr Busek
Publikováno v:
European journal of gastroenterologyhepatology. 28(7)
Risk factors (long-term diabetes, obesity) and early symptoms (new-onset diabetes, loss of weight, or persistent low body mass) are the initial symptoms of pancreatic carcinogenesis. They may be influenced by antidiabetic drugs and their correct eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::647c389b62aedbf1c2804f0c5c7a3118
https://pubmed.ncbi.nlm.nih.gov/27120389
https://pubmed.ncbi.nlm.nih.gov/27120389
Autor:
Bohuš, Bunganič, Tereza, Hálková, Lucie, Benešová, Barbora, Belšánová, Martin, Laclav, Martina, Hrůzová, Eva, Traboulsi, Přemysl, Frič, Štěpán, Suchánek, Marek, Minárik, Miroslav, Zavoral
Publikováno v:
Casopis lekaru ceskych. 155(1)
Differential diagnosis of solid pancreatic masses using EUS FNA is in 1015 % of cases still challenging. Promising method, which helps to distinguish between chronic pancreatitis and cancer, is point mutations of the proto-oncogene KRAS test. This me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d28a7239e65b0ce0f612b2d62012bb46
https://pubmed.ncbi.nlm.nih.gov/26898792
https://pubmed.ncbi.nlm.nih.gov/26898792
Autor:
Přemysl, Frič, Aleksi, Šedo, Jan, Škrha, Tomáš, Zima, Petr, Bušek, Pavel, Škrha, Klára, Kmochová, Martin, Laclav, Bohuš, Bunganič, Miroslav, Zavoral
Publikováno v:
Casopis lekaru ceskych. 155(1)
Pancreatic cancer (PC) behaves very differently in comparison with other malignancies. Its prevalence continuously increases, mortality does not decrease, diagnosis is frequently late, radical surgery is limited to 15-20 % of patients, postoperative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cec14cf9a8292f492657ecabf38414ee
https://pubmed.ncbi.nlm.nih.gov/26898791
https://pubmed.ncbi.nlm.nih.gov/26898791